Freeport-McMoRan Inc.
FCXNYSEBasic Materials● Active
$63.91
+$0.54(+0.85%)
Market Cap$91.9B
P/E Ratio—
52W High$72.09
52W Low$35.15
Freeport-McMoRan Inc.（FCX）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · FCX · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $4.05B | $3.92B | $5.97B | $8.15B | $8.07B |
| Net Receivables | $1.68B | $1.14B | $1.66B | $1.79B | $1.74B |
| Inventory | $7.49B | $6.81B | $6.06B | $5.18B | $4.50B |
| Total Current Assets | $13.79B | $13.30B | $14.06B | $15.61B | $14.83B |
| PP&E Net | $40.74B | $38.51B | $35.30B | $32.63B | $30.34B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.43B | $0.43B | $0.42B | $0.42B | $0.41B |
| Total Assets | $58.17B | $54.85B | $52.51B | $51.09B | $48.02B |
| Liabilities | |||||
| Short-Term Debt | $0.57B | $0.04B | $0.85B | $1.04B | $0.37B |
| Accounts Payable | $2.95B | $2.79B | $2.47B | $2.70B | $2.04B |
| Total Current Liabilities | $6.02B | $5.50B | $5.82B | $6.34B | $5.89B |
| Long-Term Debt | $9.92B | $8.91B | $9.00B | $9.58B | $9.08B |
| Total Liabilities | $27.40B | $26.07B | $25.20B | $26.22B | $25.00B |
| Stockholders Equity | |||||
| Retained Earnings | $1.39B | ($0.17B) | ($2.06B) | ($3.91B) | ($7.38B) |
| Total Stockholders Equity | $18.90B | $17.58B | $16.69B | $15.55B | $13.98B |
| Total Liab & Equity(computed) | $46.30B | $43.65B | $41.89B | $41.78B | $38.98B |
| Debt Summary | |||||
| Total Debt | $11.50B | $9.74B | $10.20B | $10.95B | $9.77B |
| Net Debt | $8.15B | $5.82B | $4.53B | $2.81B | $1.70B |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Freeport-McMoRan Inc.
关于Freeport-McMoRan Inc.（FCX）资产负债表
Freeport-McMoRan Inc.总资产$58.17B，现金及短期投资$4.05B，总负债$27.40B，总债务$11.50B，股东权益$18.90B。
常见问题
FCX · 4 问Freeport-McMoRan Inc.总债务$11.50B，净债务$8.15B。
FCX total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10